elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q30332596-9471F01A-FD2E-4C9A-AAFA-A736220F9EE9
Q30332596-9471F01A-FD2E-4C9A-AAFA-A736220F9EE9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30332596-9471F01A-FD2E-4C9A-AAFA-A736220F9EE9
Proteomics-based anticancer drug discovery and development.
P2860
Q30332596-9471F01A-FD2E-4C9A-AAFA-A736220F9EE9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30332596-9471F01A-FD2E-4C9A-AAFA-A736220F9EE9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
92214aac5a211d883ef0d44b8e7dd029ba9eed5e
P2860
Inhibiting signal transduction: recent advances in the development of receptor tyrosine kinase and Ras inhibitors.